| NCT Number | NCT06726590 |
| Lead Sponsor | Texas A&M University |
| Conditions | Diabetes, Cholesterol, Cancer, Blood Pressure Disorders, Heart Disease, Respiratory Ilness, COPD, Adverse Drug Reaction (ADR) +1 more |
| Enrollment | 3,000 participants |
| Start Date | 2025-11 |
| Primary Completion | 2029-11 (estimated) |
| Study Completion | 2029-11 (estimated) |
| Updated on ClinicalTrials.gov | 2025-09-12 |